title: For publication: Tiagabine in the discontinuation of long-term benzodiazepine use.
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Oulis
authors.forename: Vasilios G
authors.initials: VG
authors.lastname: Masdrakis
authors.forename: Evangelos
authors.initials: E
authors.lastname: Karapoulios
authors.forename: Nikolaos A
authors.initials: NA
authors.lastname: Karakatsanis
authors.forename: Anastasios V
authors.initials: AV
authors.lastname: Kouzoupis
authors.forename: George N
authors.initials: GN
authors.lastname: Papadimitriou
mesh_terms: D000368:Aged; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D001960:Bromazepam / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D018755:GABA Agonists / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D009557:Nipecotic Acids / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D000078308:Tiagabine
chemical_list: D018755:GABA Agonists; D006993:Hypnotics and Sedatives; D009557:Nipecotic Acids; D001569:Benzodiazepines; D001960:Bromazepam; D000078308:Tiagabine